Literature DB >> 24900605

Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties.

Ikumi Hyohdoh1, Noriyuki Furuichi1, Toshihiro Aoki1, Yoshiko Itezono1, Haruyoshi Shirai1, Sawako Ozawa1, Fumio Watanabe1, Masayuki Matsushita1, Masahiro Sakaitani1, Pil-Su Ho2, Kenji Takanashi1, Naoki Harada1, Yasushi Tomii1, Kiyoshi Yoshinari1, Kazutomo Ori1, Mitsuyasu Tabo3, Yuko Aoki1, Nobuo Shimma1, Hitoshi Iikura4.   

Abstract

A facile methodology effective in obtaining a set of compounds monofluorinated at various positions (fluorine scan) by chemical synthesis is reported. Direct and nonselective fluorination reactions of our lead compound 1a and key intermediate 2a worked efficiently to afford a total of six monofluorinated derivatives. All of the derivatives kept their physicochemical properties compared with the lead 1a and one of them had enhanced Raf/MEK inhibitory activity. Keeping physicochemical properties could be considered a benefit of monofluorinated derivatives compared with chlorinated derivatives, iodinated derivatives, methylated derivatives, etc. This key finding led to the identification of compound 14d, which had potent tumor growth inhibition in a xenograft model, excellent PK profiles in three animal species, and no critical toxicity.

Entities:  

Keywords:  Fluorine scan; MEK; Raf; anticancer; kinase inhibitor

Year:  2013        PMID: 24900605      PMCID: PMC4027529          DOI: 10.1021/ml4002419

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  14 in total

Review 1.  Atropisomerism, biphenyls, and fluorine: a comparison of rotational barriers and twist angles.

Authors:  Frédéric Leroux
Journal:  Chembiochem       Date:  2004-05-03       Impact factor: 3.164

Review 2.  Asymmetric fluorination, trifluoromethylation, and perfluoroalkylation reactions.

Authors:  Jun-An Ma; Dominique Cahard
Journal:  Chem Rev       Date:  2004-12       Impact factor: 60.622

3.  The many roles for fluorine in medicinal chemistry.

Authors:  William K Hagmann
Journal:  J Med Chem       Date:  2008-06-21       Impact factor: 7.446

4.  Chemo-enzymatic fluorination of unactivated organic compounds.

Authors:  Andrea Rentmeister; Frances H Arnold; Rudi Fasan
Journal:  Nat Chem Biol       Date:  2008-11-16       Impact factor: 15.040

Review 5.  Fluorine in medicinal chemistry.

Authors:  Hans-Joachim Böhm; David Banner; Stefanie Bendels; Manfred Kansy; Bernd Kuhn; Klaus Müller; Ulrike Obst-Sander; Martin Stahl
Journal:  Chembiochem       Date:  2004-05-03       Impact factor: 3.164

6.  Fluorine interactions at the thrombin active site: protein backbone fragments H-C(alpha)-C=O comprise a favorable C-F environment and interactions of C-F with electrophiles.

Authors:  Jacob A Olsen; David W Banner; Paul Seiler; Björn Wagner; Thomas Tschopp; Ulrike Obst-Sander; Manfred Kansy; Klaus Müller; François Diederich
Journal:  Chembiochem       Date:  2004-05-03       Impact factor: 3.164

Review 7.  Predicting and tuning physicochemical properties in lead optimization: amine basicities.

Authors:  Martin Morgenthaler; Eliane Schweizer; Anja Hoffmann-Röder; Fausta Benini; Rainer E Martin; Georg Jaeschke; Björn Wagner; Holger Fischer; Stefanie Bendels; Daniel Zimmerli; Josef Schneider; François Diederich; Manfred Kansy; Klaus Müller
Journal:  ChemMedChem       Date:  2007-08       Impact factor: 3.466

Review 8.  Understanding organofluorine chemistry. An introduction to the C-F bond.

Authors:  David O'Hagan
Journal:  Chem Soc Rev       Date:  2007-10-17       Impact factor: 54.564

Review 9.  Fluorine in pharmaceuticals: looking beyond intuition.

Authors:  Klaus Müller; Christoph Faeh; François Diederich
Journal:  Science       Date:  2007-09-28       Impact factor: 47.728

10.  Enhanced inhibition of ERK signaling by a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF activity.

Authors:  Nobuya Ishii; Naoki Harada; Eric W Joseph; Kazuhiro Ohara; Takaaki Miura; Hiroshi Sakamoto; Yutaka Matsuda; Yasushi Tomii; Yukako Tachibana-Kondo; Hitoshi Iikura; Toshihiro Aoki; Nobuo Shimma; Mikio Arisawa; Yoshihiro Sowa; Poulikos I Poulikakos; Neal Rosen; Yuko Aoki; Toshiyuki Sakai
Journal:  Cancer Res       Date:  2013-05-10       Impact factor: 12.701

View more
  5 in total

1.  From methylene bridged diindole to carbonyl linked benzimidazoleindole: Development of potent and metabolically stable PCSK9 modulators.

Authors:  Haibo Xie; Ka Yang; Gabrielle N Winston-McPherson; Donnie S Stapleton; Mark P Keller; Alan D Attie; Kerry A Smith; Weiping Tang
Journal:  Eur J Med Chem       Date:  2020-08-04       Impact factor: 6.514

2.  Palladium-catalysed electrophilic aromatic C-H fluorination.

Authors:  Kumiko Yamamoto; Jiakun Li; Jeffrey A O Garber; Julian D Rolfes; Gregory B Boursalian; Jannik C Borghs; Christophe Genicot; Jérôme Jacq; Maurice van Gastel; Frank Neese; Tobias Ritter
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

3.  Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning.

Authors:  Toshihiro Aoki; Ikumi Hyohdoh; Noriyuki Furuichi; Sawako Ozawa; Fumio Watanabe; Masayuki Matsushita; Masahiro Sakaitani; Kenji Morikami; Kenji Takanashi; Naoki Harada; Yasushi Tomii; Koji Shiraki; Kentaro Furumoto; Mitsuyasu Tabo; Kiyoshi Yoshinari; Kazutomo Ori; Yuko Aoki; Nobuo Shimma; Hitoshi Iikura
Journal:  ACS Med Chem Lett       Date:  2014-01-22       Impact factor: 4.345

4.  Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.

Authors:  Sai Fang; Lei Chen; Miao Yu; Bao Cheng; Yongsheng Lin; Susan L Morris-Natschke; Kuo-Hsiung Lee; Qiong Gu; Jun Xu
Journal:  Org Biomol Chem       Date:  2015-04-28       Impact factor: 3.876

5.  eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates.

Authors:  Limeng Pu; Misagh Naderi; Tairan Liu; Hsiao-Chun Wu; Supratik Mukhopadhyay; Michal Brylinski
Journal:  BMC Pharmacol Toxicol       Date:  2019-01-08       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.